Cargando…

pH-Responsive Nanocarriers in Cancer Therapy

A number of promising nano-sized particles (nanoparticles) have been developed to conquer the limitations of conventional chemotherapy. One of the most promising methods is stimuli-responsive nanoparticles because they enable the safe delivery of the drugs while controlling their release at the tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: AlSawaftah, Nour M., Awad, Nahid S., Pitt, William G., Husseini, Ghaleb A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912405/
https://www.ncbi.nlm.nih.gov/pubmed/35267759
http://dx.doi.org/10.3390/polym14050936
_version_ 1784667119333408768
author AlSawaftah, Nour M.
Awad, Nahid S.
Pitt, William G.
Husseini, Ghaleb A.
author_facet AlSawaftah, Nour M.
Awad, Nahid S.
Pitt, William G.
Husseini, Ghaleb A.
author_sort AlSawaftah, Nour M.
collection PubMed
description A number of promising nano-sized particles (nanoparticles) have been developed to conquer the limitations of conventional chemotherapy. One of the most promising methods is stimuli-responsive nanoparticles because they enable the safe delivery of the drugs while controlling their release at the tumor sites. Different intrinsic and extrinsic stimuli can be used to trigger drug release such as temperature, redox, ultrasound, magnetic field, and pH. The intracellular pH of solid tumors is maintained below the extracellular pH. Thus, pH-sensitive nanoparticles are highly efficient in delivering drugs to tumors compared to conventional nanoparticles. This review provides a survey of the different strategies used to develop pH-sensitive nanoparticles used in cancer therapy.
format Online
Article
Text
id pubmed-8912405
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89124052022-03-11 pH-Responsive Nanocarriers in Cancer Therapy AlSawaftah, Nour M. Awad, Nahid S. Pitt, William G. Husseini, Ghaleb A. Polymers (Basel) Review A number of promising nano-sized particles (nanoparticles) have been developed to conquer the limitations of conventional chemotherapy. One of the most promising methods is stimuli-responsive nanoparticles because they enable the safe delivery of the drugs while controlling their release at the tumor sites. Different intrinsic and extrinsic stimuli can be used to trigger drug release such as temperature, redox, ultrasound, magnetic field, and pH. The intracellular pH of solid tumors is maintained below the extracellular pH. Thus, pH-sensitive nanoparticles are highly efficient in delivering drugs to tumors compared to conventional nanoparticles. This review provides a survey of the different strategies used to develop pH-sensitive nanoparticles used in cancer therapy. MDPI 2022-02-26 /pmc/articles/PMC8912405/ /pubmed/35267759 http://dx.doi.org/10.3390/polym14050936 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
AlSawaftah, Nour M.
Awad, Nahid S.
Pitt, William G.
Husseini, Ghaleb A.
pH-Responsive Nanocarriers in Cancer Therapy
title pH-Responsive Nanocarriers in Cancer Therapy
title_full pH-Responsive Nanocarriers in Cancer Therapy
title_fullStr pH-Responsive Nanocarriers in Cancer Therapy
title_full_unstemmed pH-Responsive Nanocarriers in Cancer Therapy
title_short pH-Responsive Nanocarriers in Cancer Therapy
title_sort ph-responsive nanocarriers in cancer therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912405/
https://www.ncbi.nlm.nih.gov/pubmed/35267759
http://dx.doi.org/10.3390/polym14050936
work_keys_str_mv AT alsawaftahnourm phresponsivenanocarriersincancertherapy
AT awadnahids phresponsivenanocarriersincancertherapy
AT pittwilliamg phresponsivenanocarriersincancertherapy
AT husseinighaleba phresponsivenanocarriersincancertherapy